Deadline for applications: 23 February 2024 18:00 (KST)
The 2024 Introductory Course for Biologics Development and Manufacturing is the first edition of training courses under the program Global Training Hub for Biomanufacturing (GTH-B), supported by the South Korean Ministry of Health and Welfare (MoHW) and WHO. It focuses on the training of biomanufacturing workforce not only for Korea but for all Low- and Middle-Income Countries (LMICs) interested in the development of biomanufacturing capacity.
The 2-week course is designed as an introductory training course for the bio manufacturing workforce. It includes basic learnings across various fields related to biologics development and manufacturing. The In-Person course also offers a great chance to network with 130+ vaccine and biomanufacturing professionals worldwide.
Course Information (In-person, Seoul, South Korea)
- Course Content: Basic knowledge about pre-clinical & clinical trials, the biologics manufacturing process, quality control, quality assessment, and regulatory affairs to develop and produce vaccines and biologics.
- Course Duration: 10 working days, (2 calendar weeks)
- Faculty: Area-specific experts
- Hours of Training: 80 hours including case study, networking workshop and excursions.
- Excursion Sites: Hospital clinical centers, biomedical product development and research sites, manufacturing sites
- Target Trainees: 130 trainees from South Korea and LMICs.
- Certificate of completion: Certificates will be issued if trainee participation exceeds 90% of the whole training, which will be assessed through exams during the course.